Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 6/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 5/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | NCK1 | P16333 | 1/20 | 0.32 |
| ▸ | BACE1 | P56817 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 3/20 | 0.31 |
| ▸ | CA9 | Q16790 | 3/20 | 0.31 |
| ▸ | HSD17B14 | Q9BPX1 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6731778 | 1.00 | CYP1A2 (0.48) | CYP1A2CYP2A6TDP1LMNAALDH1A1 | |
| SCHEMBL6731076 | 0.85 | CYP1A2 (0.48) | CYP1A2CYP2A6TDP1LMNAALDH1A1 | |
| SCHEMBL14525479 | 0.84 | CYP1A2 (0.44) | CYP1A2CYP2A6TDP1LMNAALDH1A1 | |
| SCHEMBL6738004 | 0.80 | CYP2A6 (0.42) | CYP1A2CYP2A6TDP1LMNAALDH1A1 | |
| SCHEMBL8153333 | 0.80 | CYP1A2 (0.68) | CYP1A2CYP2A6TDP1LMNAALDH1A1 | |
| SCHEMBL6735680 | 0.79 | CYP1A2 (0.48) | CYP1A2CYP2A6LMNAALDH1A1GAA | |
| SCHEMBL6736398 | 0.79 | CYP1A2 (0.48) | CYP1A2CYP2A6LMNAALDH1A1GAA | |
| SCHEMBL28505827 | 0.78 | CYP2A6 (0.39) | CYP1A2CYP2A6TDP1ALDH1A1KDM4E | |
| SCHEMBL6738652 | 0.77 | CYP2A6 (0.39) | CYP1A2CYP2A6TDP1LMNAALDH1A1 | |
| SCHEMBL13480370 | 0.76 | CYP1A2 (0.44) | CYP1A2CYP2A6TDP1LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6682785-B2 | A FLUOROANTHRACENE COMPOUNDS; HEAT RESISTANCE, RADIATION RESISTANCE, PHOTOSTABILITY | CLARIANT FINANCE (BVI) LIMITED (VG) | 2004-01-27 | — | — | US | disclosed |
| US-20030118749-A1 | A fluoroanthracene compounds; heat resistance, radiation resistance, photostability | CLARIANT INTERNATIONAL LTD. | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118749-A1 | A fluoroanthracene compounds; heat resistance, radiation resistance, photostability | HSF1, ABCC1, FLNA | CYP1A2 80/4885CYP2A6 1066/4885TDP1 732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.